Coinspeaker SNG Stock Soars 470% as Synairgen Reports Promising COVID-19 Vaccine Trial ResultsFollowing the company's announcement about the success of its COVID-19 vaccine, Synairgen stock has increased significantly. Now it is nearly 470% up.SNG Stock Soars 470% as Synairgen Reports Promising COVID-19 Vaccine Trial Results